Mizuno M, Yoshida J
Department of Neurosurgery, Nagoya University School of Medicine.
Jpn J Cancer Res. 1998 Apr;89(4):352-4. doi: 10.1111/j.1349-7006.1998.tb00570.x.
Recombinant adeno-associated virus (AAV) has attracted considerable interest as a potential vector for human gene therapy, but its transduction efficiency is quite low. The present study demonstrated AAV vector-associated liposomes to be more effective for in vitro gene transfer to human glioma cells than are liposomes containing plasmid DNA. Using vector-associated liposomes increased the transduction efficiency more than 10-fold compared to liposomes containing plasmid DNA and more than 6-fold compared to AAV alone. From these results, AAV vector-associated liposomes appear to be a good candidate for in vivo gene delivery to human gliomas.
重组腺相关病毒(AAV)作为一种潜在的人类基因治疗载体已引起了广泛关注,但其转导效率相当低。本研究表明,与含有质粒DNA的脂质体相比,AAV载体相关脂质体在体外对人胶质瘤细胞进行基因转移时更有效。与含有质粒DNA的脂质体相比,使用载体相关脂质体可使转导效率提高10倍以上,与单独使用AAV相比可提高6倍以上。基于这些结果,AAV载体相关脂质体似乎是用于人胶质瘤体内基因递送的良好候选物。